Literature DB >> 6263122

The ecology of Colorado tick fever in Rocky Mountain National Park in 1974. II. Infection in small mammals.

G S Bowen, R G McLean, R B Shriner, D B Francy, K S Pokorny, J M Trimble, R A Bolin, A M Barnes, C H Calisher, D J Muth.   

Abstract

Field studies of Colorado tick fever (CTF) in small mammals in Rocky Mountain National Park (RMNP) in 1974 established that Eutamias minimus and Spermophilus lateralis were the most important hosts for CTF virus and were the source of virus for immature stages of the tick vector, Dermacentor andersoni. Other species (Peromyscus maniculatus, Spermophilus richardsonii, Eutamias umbrinus) are secondary hosts. The intensity of viral activity in rodents varied greatly from locality to locality. Highest rodent infection rates were found to occur in the Moraine Park area of RMNP. Lowest infection rates occurred above 3,290 meters in altitude at Rainbow Curve and on the tundra. The prevalence of infection in rodents was constant from April--July (5--6% of animals captured were viremic) and then declined to 1.7--2.5% in August and September coincident with a decline in nymphal tick ectoparasitism. Many animals were captured which were simultaneously viremic and antibody-positive. Under field conditions, neutralizing antibody seroconversion does not always occur.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263122     DOI: 10.4269/ajtmh.1981.30.490

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  What is the risk for exposure to vector-borne pathogens in United States national parks?

Authors:  Lars Eisen; David Wong; Victoria Shelus; Rebecca J Eisen
Journal:  J Med Entomol       Date:  2013-03       Impact factor: 2.278

Review 2.  Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.

Authors:  Hamid Salimi; Matthew D Cain; Robyn S Klein
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.